Answers are grounded in this paper and cite their sources.
Finds HIV prevalence declines in Kinshasa, suggesting elimination is feasible in some areas.
Kinshasa was the crucible of the HIV pandemic, the only place on Earth where its path can be tracked over a century through history, demography, evolutionary biology, epidemiological studies, and population-based surveys. Altogether, these tools demonstrate that HIV is fading away from Kinshasa. Between HIV's arrival (≈1916) and the last survey (2023-2024), Kinshasa's population increased from 14 000 to 17 million inhabitants. After an exponential growth of persons with HIV (PWH) from the mid-1950s until 1988, this stalled between 1988 and 2013-2014. From 85 900 PWH in 2013-2014, this number dropped to 35 500 in 2023-2024, while population increased by 6 million. After culminating at ≈4.8% (1988), prevalence in persons aged 15-49 years now stands at 0.4% (2023-2024). While 35% of sex workers were infected in 1988, this proportion decreased to 12% in 2002, 10% in 2012 and only 5% in 2018-2019. Safer sex, antiretrovirals, and internal migrations from lower-prevalence rural regions contributed to HIV's decline, an evolution facilitated by a long-standing and almost universal practice of circumcision. Alterations in sex work patterns may have been pivotal: economic hardship and risk awareness stifled demand, fewer clients and higher condom use attenuated the risk for sex workers which in turn protected their subsequent clients. A virtuous cycle might have taken hold. Genetic factors enhancing biological susceptibility to HIV could have rarefied through a combination of mechanisms. This unrelenting downward trend over four decades suggests that the 'elimination' of HIV, at least in certain areas, is feasible.
No takes yet. Share an insight, caveat, or question.
Jacques Pépin (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: